Economic implications of COPD addressed in Europe

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.383, 2002-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COPD: economic impact of new bronchodilators

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Levosalbutamol yields "economic advantages" in asthma, COPD

By  

Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery

By Schamberger Andrea C   Mise Nikica   Meiners Silke   Eickelberg Oliver  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 609-628

Informa Healthcare

Access to resources Recommend Favorite

Economic Implications of Sleep Disorders

By Skaer Tracy L.   Sclar David A.  

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1015-1023

Adis International

Access to resources Recommend Favorite

Economic evaluation of osteoarthritis treatment in Europe

By Gillette Jennifer A   Tarricone Rosanna  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 327-341

Informa Healthcare

Access to resources Recommend Favorite